Literature DB >> 2455130

Regression of cardiac hypertrophy after antihypertensive therapy with nifedipine and captopril.

I Sheiban1, G Arcaro, G Covi, R Accardi, C Zenorini, A Lechi.   

Abstract

The effects of two antihypertensive agents, nifedipine (n class="Chemical">N) and captopril (C), on left ventricular (LV) mass and volume were studied in 16 patients with essential hypertension (8 treated with N and 8 with C for 6 months) by means of a complete M-mode echocardiogram monitored by two-dimensional echocardiography. Both N and C induced a significant reduction in end-diastolic, but not systolic, posterior wall and septum thickness and an increase in end-diastolic volume, but not in end-systolic volume. A significant increase in the contribution of rapid filling together with a simultaneous reduction in the contribution of atrial systole to end diastolic volume were also observed. The reduction in LV wall thickness and mass after both C and N might be attributed to an improvement in diastolic function and to a reduction in wall tension, rather than to an effective regression of LV hypertrophy.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2455130

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  4 in total

1.  Early regression of left ventricular diastolic abnormalities in hypertensive patients treated with nifedipine.

Authors:  I Sheiban; G Covi; C Zenorini; G Arcaro; E Arosio; S Tonni; G Montresor; A Lechi
Journal:  Cardiovasc Drugs Ther       Date:  1990-08       Impact factor: 3.727

2.  Left ventricular diastolic function during adrenergic stress in essential hypertension: acute and chronic effects of ACE inhibition.

Authors:  G Covi; I Sheiban; G Gelmini; G Arcaro; S Tonni; A Bolner; G Piemonte; A Lechi
Journal:  Cardiovasc Drugs Ther       Date:  1996-07       Impact factor: 3.727

Review 3.  Captopril. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.

Authors:  R N Brogden; P A Todd; E M Sorkin
Journal:  Drugs       Date:  1988-11       Impact factor: 9.546

4.  Modifications in peripheral hemodynamics and left ventricular function in hypertensives treated with nicardipine slow release.

Authors:  E Arosio; P Pancera; I Seiban; F Priante; M Ribul; S De Marchi; G Montresor; A Lechi
Journal:  Cardiovasc Drugs Ther       Date:  1994-02       Impact factor: 3.727

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.